INSIGHTS ON DRUG DEVELOPMENT

• How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics

  CRISPR gene editing and lipid nanoparticle delivery are revolutionizing precision medicine. Discover how optimized LNP systems and advanced analytics accelerate therapeutic development.

• Softgel Formulation Strategies For Challenging Oral Compounds

  Explore strategies to solve solubility and permeability challenges, boost oral bioavailability, and ensure consistent absorption — reducing risk and unlocking complex molecules.

• Ask Us Anything: Anmaris Torres On The First Steps In Process Transfer

  Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.

• Exosome Production From hMSC Using A Fixed-Bed Bioreactor

  Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.

• Don't Let Your Filling Equipment Dictate Your Drug Formulation

  6/1/2026

  Gravimetric powder dosing measures true mass to eliminate equipment-driven reformulation, preserving particle design and speeding clinical development.

• Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development

  6/19/2025

  Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

• Why Biopharma Breakthroughs Aren't Moving The Market

  10/20/2025

  Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.

• Is Lipinski's Rule Of Five Still Relevant In Drug Development?

  11/13/2024

  Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.

• Ask Us Anything: David Ford On AI And Automation Trends

  7/23/2026

  David Ford, Senior Director of Chemistry at Snapdragon Chemistry, on the mountain of data behind every process development program — and why AI's real promise is surfacing the right piece of it at the moment a team needs to decide.